XTANDI QUICK START+® Program
The XTANDI QUICK START+® Program provides a one-time, 14-day supply of XTANDI® (enzalutamide) at no cost to new eligible patients who experience a delay in insurance coverage.
- Patient eligibility requirements for this program include but are not limited to:
- Have prescription drug insurance
- Be new to XTANDI therapy
- Have experienced an insurance-related access delay
- Have been prescribed XTANDI for an FDA-approved indication
- Offers overnight shipping directly to the patient
QUICK START+® is a registered trademark of Astellas US LLC.
XTANDI® is a registered trademark of Astellas Pharma Inc.